Clinical and functional Characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy

Ray E. Hershberger, Jose Renato Pinto, Sharie B. Parks, Jessica Kushner, Duanxiang Li, Susan Ludwigsen, Jason Cowan, Ana Morales, Michelle S. Parvatiyar, James D. Potter

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Background-A key issue for cardiovascular genetic medicine is ascertaining if a putative mutation indeed causes dilated cardiomyopathy (DCM). This is critically important as genetic DCM, usually presenting with advanced, life-threatening disease, may be preventable with early intervention in relatives known to carry the mutation. Methods and Results-We recently undertook bidirectional resequencing of TNNT2, the cardiac troponin T gene, in 313 probands with DCM. We identified 6 TNNT2 protein-altering variants in 9 probands, all who had early onset, aggressive disease. Additional family members of mutation carriers were then studied when available. Four of the 9 probands had DCM without a family history, and 5 probands had familial DCM. Only 1 mutation (Lys210del) could be attributed as definitively causative from previous reports. Four of the 5 missense mutations were novel (Arg134Gly, Arg151Cys, Arg159Gln, and Arg205Trp), and one was previously reported with hypertrophic cardiomyopathy (Glu244Asp). Based on the clinical, pedigree, and molecular genetic data, these 5 mutations were considered possibly or likely disease causing. To further clarify their potential pathophysiologic impact, we undertook functional studies of these mutations in cardiac myocytes reconstituted with mutant troponin T proteins. We observed decreased Ca 2+ sensitivity of force development, a hallmark of DCM, in support of the conclusion that these mutations are disease causing. Conclusions-We conclude that the combination of clinical, pedigree, molecular genetic, and functional data strengthen the interpretation of TNNT2 mutations in DCM.

Original languageEnglish (US)
Pages (from-to)306-313
Number of pages8
JournalCirculation: Cardiovascular Genetics
Volume2
Issue number4
DOIs
StatePublished - Aug 2009

Fingerprint

Dilated Cardiomyopathy
Mutation
Troponin T
Pedigree
Molecular Biology
Hypertrophic Cardiomyopathy
Missense Mutation
Cardiac Myocytes
Proteins
Medicine
Genes

Keywords

  • Dilated cardiomyopathy
  • Genetics
  • Troponin T

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Genetics(clinical)
  • Genetics
  • Medicine(all)

Cite this

Hershberger, R. E., Pinto, J. R., Parks, S. B., Kushner, J., Li, D., Ludwigsen, S., ... Potter, J. D. (2009). Clinical and functional Characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy. Circulation: Cardiovascular Genetics, 2(4), 306-313. https://doi.org/10.1161/CIRCGENETICS.108.846733

Clinical and functional Characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy. / Hershberger, Ray E.; Pinto, Jose Renato; Parks, Sharie B.; Kushner, Jessica; Li, Duanxiang; Ludwigsen, Susan; Cowan, Jason; Morales, Ana; Parvatiyar, Michelle S.; Potter, James D.

In: Circulation: Cardiovascular Genetics, Vol. 2, No. 4, 08.2009, p. 306-313.

Research output: Contribution to journalArticle

Hershberger, RE, Pinto, JR, Parks, SB, Kushner, J, Li, D, Ludwigsen, S, Cowan, J, Morales, A, Parvatiyar, MS & Potter, JD 2009, 'Clinical and functional Characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy', Circulation: Cardiovascular Genetics, vol. 2, no. 4, pp. 306-313. https://doi.org/10.1161/CIRCGENETICS.108.846733
Hershberger, Ray E. ; Pinto, Jose Renato ; Parks, Sharie B. ; Kushner, Jessica ; Li, Duanxiang ; Ludwigsen, Susan ; Cowan, Jason ; Morales, Ana ; Parvatiyar, Michelle S. ; Potter, James D. / Clinical and functional Characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy. In: Circulation: Cardiovascular Genetics. 2009 ; Vol. 2, No. 4. pp. 306-313.
@article{22148e1de2f644648dae44d9aad13668,
title = "Clinical and functional Characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy",
abstract = "Background-A key issue for cardiovascular genetic medicine is ascertaining if a putative mutation indeed causes dilated cardiomyopathy (DCM). This is critically important as genetic DCM, usually presenting with advanced, life-threatening disease, may be preventable with early intervention in relatives known to carry the mutation. Methods and Results-We recently undertook bidirectional resequencing of TNNT2, the cardiac troponin T gene, in 313 probands with DCM. We identified 6 TNNT2 protein-altering variants in 9 probands, all who had early onset, aggressive disease. Additional family members of mutation carriers were then studied when available. Four of the 9 probands had DCM without a family history, and 5 probands had familial DCM. Only 1 mutation (Lys210del) could be attributed as definitively causative from previous reports. Four of the 5 missense mutations were novel (Arg134Gly, Arg151Cys, Arg159Gln, and Arg205Trp), and one was previously reported with hypertrophic cardiomyopathy (Glu244Asp). Based on the clinical, pedigree, and molecular genetic data, these 5 mutations were considered possibly or likely disease causing. To further clarify their potential pathophysiologic impact, we undertook functional studies of these mutations in cardiac myocytes reconstituted with mutant troponin T proteins. We observed decreased Ca 2+ sensitivity of force development, a hallmark of DCM, in support of the conclusion that these mutations are disease causing. Conclusions-We conclude that the combination of clinical, pedigree, molecular genetic, and functional data strengthen the interpretation of TNNT2 mutations in DCM.",
keywords = "Dilated cardiomyopathy, Genetics, Troponin T",
author = "Hershberger, {Ray E.} and Pinto, {Jose Renato} and Parks, {Sharie B.} and Jessica Kushner and Duanxiang Li and Susan Ludwigsen and Jason Cowan and Ana Morales and Parvatiyar, {Michelle S.} and Potter, {James D.}",
year = "2009",
month = "8",
doi = "10.1161/CIRCGENETICS.108.846733",
language = "English (US)",
volume = "2",
pages = "306--313",
journal = "Circulation. Genomic and precision medicine",
issn = "1942-325X",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "4",

}

TY - JOUR

T1 - Clinical and functional Characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy

AU - Hershberger, Ray E.

AU - Pinto, Jose Renato

AU - Parks, Sharie B.

AU - Kushner, Jessica

AU - Li, Duanxiang

AU - Ludwigsen, Susan

AU - Cowan, Jason

AU - Morales, Ana

AU - Parvatiyar, Michelle S.

AU - Potter, James D.

PY - 2009/8

Y1 - 2009/8

N2 - Background-A key issue for cardiovascular genetic medicine is ascertaining if a putative mutation indeed causes dilated cardiomyopathy (DCM). This is critically important as genetic DCM, usually presenting with advanced, life-threatening disease, may be preventable with early intervention in relatives known to carry the mutation. Methods and Results-We recently undertook bidirectional resequencing of TNNT2, the cardiac troponin T gene, in 313 probands with DCM. We identified 6 TNNT2 protein-altering variants in 9 probands, all who had early onset, aggressive disease. Additional family members of mutation carriers were then studied when available. Four of the 9 probands had DCM without a family history, and 5 probands had familial DCM. Only 1 mutation (Lys210del) could be attributed as definitively causative from previous reports. Four of the 5 missense mutations were novel (Arg134Gly, Arg151Cys, Arg159Gln, and Arg205Trp), and one was previously reported with hypertrophic cardiomyopathy (Glu244Asp). Based on the clinical, pedigree, and molecular genetic data, these 5 mutations were considered possibly or likely disease causing. To further clarify their potential pathophysiologic impact, we undertook functional studies of these mutations in cardiac myocytes reconstituted with mutant troponin T proteins. We observed decreased Ca 2+ sensitivity of force development, a hallmark of DCM, in support of the conclusion that these mutations are disease causing. Conclusions-We conclude that the combination of clinical, pedigree, molecular genetic, and functional data strengthen the interpretation of TNNT2 mutations in DCM.

AB - Background-A key issue for cardiovascular genetic medicine is ascertaining if a putative mutation indeed causes dilated cardiomyopathy (DCM). This is critically important as genetic DCM, usually presenting with advanced, life-threatening disease, may be preventable with early intervention in relatives known to carry the mutation. Methods and Results-We recently undertook bidirectional resequencing of TNNT2, the cardiac troponin T gene, in 313 probands with DCM. We identified 6 TNNT2 protein-altering variants in 9 probands, all who had early onset, aggressive disease. Additional family members of mutation carriers were then studied when available. Four of the 9 probands had DCM without a family history, and 5 probands had familial DCM. Only 1 mutation (Lys210del) could be attributed as definitively causative from previous reports. Four of the 5 missense mutations were novel (Arg134Gly, Arg151Cys, Arg159Gln, and Arg205Trp), and one was previously reported with hypertrophic cardiomyopathy (Glu244Asp). Based on the clinical, pedigree, and molecular genetic data, these 5 mutations were considered possibly or likely disease causing. To further clarify their potential pathophysiologic impact, we undertook functional studies of these mutations in cardiac myocytes reconstituted with mutant troponin T proteins. We observed decreased Ca 2+ sensitivity of force development, a hallmark of DCM, in support of the conclusion that these mutations are disease causing. Conclusions-We conclude that the combination of clinical, pedigree, molecular genetic, and functional data strengthen the interpretation of TNNT2 mutations in DCM.

KW - Dilated cardiomyopathy

KW - Genetics

KW - Troponin T

UR - http://www.scopus.com/inward/record.url?scp=77449104814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77449104814&partnerID=8YFLogxK

U2 - 10.1161/CIRCGENETICS.108.846733

DO - 10.1161/CIRCGENETICS.108.846733

M3 - Article

C2 - 20031601

AN - SCOPUS:77449104814

VL - 2

SP - 306

EP - 313

JO - Circulation. Genomic and precision medicine

JF - Circulation. Genomic and precision medicine

SN - 1942-325X

IS - 4

ER -